Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Moore

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Respirology Case Reports|August 6, 2025
Guillain-Barre Syndrome in Patients With Cystic Fibrosis: A Case SeriesJames Nolan, Maxter Thai, Vanessa Moore, et al.
Journal of Clinical Medicine|February 26, 2025
Cost-Effectiveness of Routine X-Rays After Central Venous Catheter Removal: A Value-Based Analysis of Post-Removal ComplicationsMartin Breitwieser, Teresa Wiesner, Vanessa Moore, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
NLP-Driven Analysis of Pneumothorax Incidence Following Central Venous Catheter Procedures: A Data-Driven Re-Evaluation of Routine Imaging in Value-Based MedicineMartin Breitwieser, Vanessa Moore, Teresa Wiesner, et al.
Journal of Clinical Medicine|October 26, 2024
Phenotypic Evaluation of Rare Cystic Fibrosis Transmembrane Conductance Regulator Mutation Combinations in People with Cystic Fibrosis in Queensland, AustraliaIeuan Edward Shepherd Evans, Michelle Wood, Vanessa Moore, et al.
Infection and Immunity|July 27, 2011
Functional and phenotypic characteristics of alternative activation induced in human monocytes by interleukin-4 or the parasitic nematode Brugia malayiRoshanak Tolouei Semnani, Lily Mahapatra, Vanessa Moore, et al.
Pharmaceutical Research|April 3, 2003
An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routesStaffan Tavelin, Jan Taipalensuu, Finn Hallböök, et al.
International Journal of Pharmaceutics|August 7, 2008
The gastrointestinal microbiota as a site for the biotransformation of drugsTiago Sousa, Ronnie Paterson, Vanessa Moore, et al.
JBI Evidence Implementation|April 17, 2026
Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods studyAngela G Matson, Daniel Smith, Felicity Loel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cellsHannah M Prime-Chapman, Richard A Fearn, Anne E Cooper, et al.
BMC Pulmonary Medicine|January 19, 2020
Current infection control practices used in Australian and New Zealand cystic fibrosis centersRebecca Elizabeth Stockwell, Michelle ELizabeth Wood, Emma Ballard, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Respirology Case Reports|August 6, 2025
Guillain-Barre Syndrome in Patients With Cystic Fibrosis: A Case SeriesJames Nolan, Maxter Thai, Vanessa Moore, et al.
Journal of Clinical Medicine|February 26, 2025
Cost-Effectiveness of Routine X-Rays After Central Venous Catheter Removal: A Value-Based Analysis of Post-Removal ComplicationsMartin Breitwieser, Teresa Wiesner, Vanessa Moore, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
NLP-Driven Analysis of Pneumothorax Incidence Following Central Venous Catheter Procedures: A Data-Driven Re-Evaluation of Routine Imaging in Value-Based MedicineMartin Breitwieser, Vanessa Moore, Teresa Wiesner, et al.
Journal of Clinical Medicine|October 26, 2024
Phenotypic Evaluation of Rare Cystic Fibrosis Transmembrane Conductance Regulator Mutation Combinations in People with Cystic Fibrosis in Queensland, AustraliaIeuan Edward Shepherd Evans, Michelle Wood, Vanessa Moore, et al.
Infection and Immunity|July 27, 2011
Functional and phenotypic characteristics of alternative activation induced in human monocytes by interleukin-4 or the parasitic nematode Brugia malayiRoshanak Tolouei Semnani, Lily Mahapatra, Vanessa Moore, et al.
Pharmaceutical Research|April 3, 2003
An improved cell culture model based on 2/4/A1 cell monolayers for studies of intestinal drug transport: characterization of transport routesStaffan Tavelin, Jan Taipalensuu, Finn Hallböök, et al.
International Journal of Pharmaceutics|August 7, 2008
The gastrointestinal microbiota as a site for the biotransformation of drugsTiago Sousa, Ronnie Paterson, Vanessa Moore, et al.
JBI Evidence Implementation|April 17, 2026
Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods studyAngela G Matson, Daniel Smith, Felicity Loel, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cellsHannah M Prime-Chapman, Richard A Fearn, Anne E Cooper, et al.
BMC Pulmonary Medicine|January 19, 2020
Current infection control practices used in Australian and New Zealand cystic fibrosis centersRebecca Elizabeth Stockwell, Michelle ELizabeth Wood, Emma Ballard, et al.
Pageof 3